Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001209191-22-029091

Chief Financial Officer bought 85,000 shares at $5.79 ($492,150)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Booth Andrew Chief Financial Officer 2022-05-12 Purchase +85,000 $5.79 $492,150 138,500 D
Open-market purchases · 85,000 sh · avg $5.79 · $492,150
Loading xslF345X03/doc4.xml…